Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BGB-A425 |
Trade Name | |
Synonyms | BGBA425|BGB A425 |
Drug Descriptions |
BGB-A425 is an antibody that targets Tim-3, potentially resulting in enhanced anti-tumor immune response and decreased tumor growth (Cancer Res July 1 2017 (77) (13 Supplement) 2628). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C157242 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BGB-A425 | BGB-A425 | 0 | 0 |
BGB-A425 + LBL-007 + Tislelizumab | BGB-A425 LBL-007 Tislelizumab | 0 | 1 |
BGB-A425 + Tislelizumab | BGB-A425 Tislelizumab | 0 | 2 |